Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Universal Music Group and TikTok Announce New Global Licensing Agreement
-
The Broken Command Center: New Doceree Survey Documents the Structural Cost of Pharma's Fragmented Marketing Stack
-
Agilent Unveils the 9500 ICP-MS: Redefining Trace Element Analysis
-
Henry Schein Announces the Election of William K. “Dan” Daniel as Independent Chairman of the Board
-
AI & Tech Sandbox Unveils Cannes Lions 2026 Programming Focused on Learning, Discovery, and What’s Next in AI
-
AbbVie Announces Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir) for the Treatment of Acute Hepatitis C Infection
-
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors
-
BBRC Corrects the Record on Victoria’s Secret’s Investor Presentation
-
Rivian to Participate at Upcoming Investor Conferences
-
Hamilton ETFs Announces May 2026 Monthly & Upcoming Semi-Monthly Cash Distributions
-
Nakamoto Announces Expansion of Board of Directors
-
KB HOME OPENS SUNSET RIDGE: NEW HOMES FROM THE LOW $500Ks IN DESIRABLE SPANAWAY, WASHINGTON
-
SBC Medical and BLEZ ASIA Celebrate Opening of New Aesthetic Dermatology Section at BLEZ CLINIC in Bangkok
-
WRAP® Developing Directional Light Scenarios and Non-Lethal Response (NLR) Technologies for WrapReality® VR Training Platform
-
NTT, NTT DATA and INDYCAR Extend Entitlement Partnership with Multi-Year Agreement
-
Max Power Expands and Accelerates Its Commercial Validation Program for Canada’s First Natural Hydrogen System
-
Global Ship Lease Reports Results for the First Quarter of 2026
-
Veracyte to Host Investor Call on June 1, 2026 to Discuss ASCO Findings
-
Operation HOPE’s First Quarter 2026 HOPE Insider Survey Reveals Economic Anxiety Persists, but Financial Literacy Support is Building Resilience
-
2026 ASCO | Pivotal Data of InnoCare's Novel BCL2 Inhibitor Mesutoclax Released
-
BitFuFu to Report First Quarter 2026 Unaudited Financial Results on May 29, 2026
-
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
-
SunPower Adds $5M to Recent $41M Offering
-
Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification
-
EQ Inc. Reports First Quarter 2026 Financial Results and Annual General Meeting Results
-
XRPPower Combines Blockchain Infrastructure with AI-Powered Trading Automation to Streamline Daily Asset Settlement
-
American Rebel CEO - Andy Ross to Open for Brantley Gilbert, Aaron Lewis, and Payton Smith in a High-Energy, Patriotic Memorial Weekend Concert Event as American Rebel Light Beer Becomes Official Beer
-
Slate Grocery REIT Special Committee to Review Strategic Alternatives
-
ABM to Announce Second Quarter 2026 Financial Results
-
GraniteShares Announces Weekly Distributions for its YieldBOOST FoFs ETFs: YBST and YBTY
-
Dateline Appoints Alvarez & Marsal to Manage Colosseum Development
-
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
-
Walmart Leadership to Participate in Upcoming Investor Events
-
Imagine Health Achieves Teaching Facility Status Through University of Calgary Faculty Partnership
-
Cleantech REPS gets $23.6M to turn road traffic into clean electricity at scale
-
CCL Industries Inc. Announces Renewal of Normal Course Issuer Bid and Approval of Automatic Securities Purchase Plan
-
New River Electrical Corporation Appoints Chris Berk as Vice President of Information Technology
-
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Cisplatin-Ineligible Resectable Muscle-Invasiv
-
Koppers Management Participating in Barrington Research Spring Investment Conference
-
Contract Professionals, Inc. Founder Steve York Announces Retirement After 44 Years
-
Execution of SwissASC spin-out and related disposals
-
Lingerfelt Announces its Sale of Ashton Creek Distribution Center
-
PenFed Credit Union Continues Partnership with Goulian Aerosports for the 2026 Air Show Season
-
Gilead Receives CHMP Positive Opinion for Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer for Patients Not Candidates for PD-(L)1 Inhibitors
-
Why Does a Pet Food Label Tell You Almost Nothing About What's Actually Invisible in the Bag?
-
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly
-
Pharma Warehouse Temperature Monitoring Solutions
-
Deutsche Lufthansa AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
-
Classover Enters into $100 Million Equity Purchase Facility Agreement and Announces Expansion into AI Compute Infrastructure and Cloud Services Platforms
-
STARTRADER CEO Peter Karsten Joins University of Europe for Three Sessions Spanning AI Infrastructure, Business Operations, and Market Risk

